GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (STU:WSG) » Definitions » Capex-to-Revenue

China Traditional Chinese Medicine Holdings Co (STU:WSG) Capex-to-Revenue : 0.03 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

China Traditional Chinese Medicine Holdings Co's Capital Expenditure for the six months ended in Jun. 2024 was €-29.13 Mil. Its Revenue for the six months ended in Jun. 2024 was €1,073.80 Mil.

Hence, China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue for the six months ended in Jun. 2024 was 0.03.


China Traditional Chinese Medicine Holdings Co Capex-to-Revenue Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Traditional Chinese Medicine Holdings Co Capex-to-Revenue Chart

China Traditional Chinese Medicine Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.09 0.05 0.04 0.03

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.03 0.03 0.03 0.03

Competitive Comparison of China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue falls into.



China Traditional Chinese Medicine Holdings Co Capex-to-Revenue Calculation

China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-62.751) / 2327.35
=0.03

China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-29.134) / 1073.801
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Traditional Chinese Medicine Holdings Co  (STU:WSG) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


China Traditional Chinese Medicine Holdings Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Traditional Chinese Medicine Holdings Co Business Description

Traded in Other Exchanges
Address
288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China.

China Traditional Chinese Medicine Holdings Co Headlines

From GuruFocus